1. The Microenvironment of the Pathogenesis of Cardiac Hypertrophy
    Farhad Bazgir et al, 2023, Cells CrossRef
  2. Genistein reverses isoproterenol-induced cardiac hypertrophy by regulating miR-451/TIMP2
    Mailin Gan et al, 2019, Biomedicine & Pharmacotherapy CrossRef
  3. F‑box and WD repeat‑containing protein 7 ameliorates angiotensin II‑induced myocardial hypertrophic injury via the mTOR‑mediated autophagy pathway
    Qiang Liu et al, 2022, Experimental and Therapeutic Medicine CrossRef
  4. Hypertension
    Rebecca F. Geddes, 2020, Veterinary Clinics of North America: Small Animal Practice CrossRef
  5. Sinomenine ameliorates cardiac hypertrophy by activating Nrf2/ARE signaling pathway
    ManLi Yuan et al, 2021, Bioengineered CrossRef
  6. Betulinic Acid Improves Cardiac-Renal Dysfunction Caused by Hypertrophy through Calcineurin-NFATc3 Signaling
    Mi-Hyeon Hong et al, 2021, Nutrients CrossRef
  7. Inhibiting SLC26A4 reverses cardiac hypertrophy in H9C2 cells and in rats
    Liqun Tang et al, 2020, PeerJ CrossRef
  8. Taurine prevents cardiomyocyte apoptosis by inhibiting the calpain-1/cytochrome c pathway during RVH in broilers
    Weiwei Li et al, 2020, Amino Acids CrossRef
  9. 16α-OHE1 alleviates hypoxia-induced inflammation and myocardial damage via the activation of β2-Adrenergic receptor
    Yequan Zhou et al, 2024, Molecular and Cellular Endocrinology CrossRef
  10. Leu27IGF‐II‐induced hypertrophy in H9c2 cardiomyoblasts is ameliorated by saffron by regulation of calcineurin/NFAT and CaMKIIδ signaling
    Chin‐Yi Lin et al, 2021, Environmental Toxicology CrossRef
  11. Loganin Inhibits Angiotensin II–Induced Cardiac Hypertrophy Through the JAK2/STAT3 and NF-κB Signaling Pathways
    Jia-jia Xu et al, 2021, Frontiers in Pharmacology CrossRef
  12. Mitofilin in cardiovascular diseases: Insights into the pathogenesis and potential pharmacological interventions
    Abdallah Iddy Chaurembo et al, 2024, Pharmacological Research CrossRef
  13. G6PD, bond by miR-24, regulates mitochondrial dysfunction and oxidative stress in phenylephrine-induced hypertrophic cardiomyocytes
    Bing Li et al, 2020, Life Sciences CrossRef
  14. Sesamin suppresses angiotensin‐II‐enhanced oxidative stress and hypertrophic markers in H9c2 cells
    Chih‐Chia Chang et al, 2023, Environmental Toxicology CrossRef
  15. Telmisartan cardioprotects from the ischaemic/hypoxic damage through a miR‐1‐dependent pathway
    Maria Consiglia Trotta et al, 2019, Journal of Cellular and Molecular Medicine CrossRef
  16. The Pathophysiology of Afterload Mismatch and Ventricular Hypertrophy
    Blase A. Carabello, 2021, Structural Heart CrossRef
  17. The adiponectin signalling pathway - A therapeutic target for the cardiac complications of type 2 diabetes?
    Abhipree Sharma et al, 2022, Pharmacology & Therapeutics CrossRef
  18. Yi-Xin-Shu capsule ameliorates cardiac hypertrophy by regulating RB/HDAC1/GATA4 signaling pathway based on proteomic and mass spectrometry image analysis
    Minyu Zhang et al, 2022, Phytomedicine CrossRef
  19. Virtual drug screen reveals context‐dependent inhibition of cardiomyocyte hypertrophy
    Taylor G. Eggertsen et al, 2023, British Journal of Pharmacology CrossRef
  20. Potential inhibitory effect of geraniol isolated from lemongrass ( Cymbopogon commutatus Stapf) on tilmicosin-induced oxidative stress in cardiac tissue
    Rebai Ben Ammar et al, 2024, Natural Product Research CrossRef
  21. Rhein ameliorates transverse aortic constriction-induced cardiac hypertrophy via regulating STAT3 and p38 MAPK signaling pathways
    Run-Jing Li et al, 2022, Frontiers in Pharmacology CrossRef
  22. Sibjotang Protects against Cardiac Hypertrophy In Vitro and In Vivo
    Chan-Ok Son et al, 2023, Life CrossRef
  23. Secreted frizzled-related protein 3 alleviated cardiac remodeling induced by angiotensin II via inhibiting oxidative stress and apoptosis in mice
    Yang Gu et al, 2022, European Journal of Pharmacology CrossRef
  24. Nrf2 deficiency aggravates PM2.5-induced cardiomyopathy by enhancing oxidative stress, fibrosis and inflammation via RIPK3-regulated mitochondrial disorder
    Chenxu Ge et al, 2020, Aging CrossRef
  25. Mechanisms for the transition from physiological to pathological cardiac hypertrophy
    Christopher J. Oldfield et al, 2020, Canadian Journal of Physiology and Pharmacology CrossRef
  26. The Expression of microRNA in Adult Rat Heart with Isoproterenol-Induced Cardiac Hypertrophy
    Mailin Gan et al, 2020, Cells CrossRef